Results 191 to 200 of about 91,896 (245)

Coronavirus disease 2019 infection reduces EGFR‐TKI efficacy in non‐small cell lung carcinoma: Real‐world evidence from a multicenter propensity‐matched cohort

International Journal of Cancer, EarlyView.
What's New? Lung cancer patients with COVID‐19 experience significantly increased risk for severe illness and mortality. However, research addressing the effect of COVID‐19 on non‐small cell lung cancer (NSCLC) patients treated with epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) remains unknown.
Wenjie Tang, Xiaoxuan Hou, Li Li, Hanxi Zhao, Xiaoyong Tang, Wanqi Zhu, Xiaohui Yan, Jing Liu, Qian Wu, Zhu Qiao, Shanliang Hu, Mingwei Zhang, Xiaolin Li, Peng Xie   +13 more
wiley   +1 more source

Real-world single-center analysis of efficacy and safety in newly diagnosed marginal zone lymphoma. [PDF]

Clin Exp Med
Zhou X, Ruan J, Shi Y, Shan N.
europepmc   +1 more source

Immune Checkpoint Blockade in Hematological Malignancies: Current Status and Future Directions. [PDF]

Cancers (Basel)
Lau HC, Kwong YL.
europepmc   +1 more source

From mechanism to phenotype: What fits in a basket trial

Epilepsia, EarlyView.
Kette D. Valente
wiley   +1 more source

Immunotherapy in hepatocellular carcinoma: translating mechanistic insights into clinical advances. [PDF]

Clin Exp Med
Khorasani SK, Boroumandi S, Darzi A, Shokouhfar M, Abdali P, Eini P, Vanan AG, Bahrami N.   +7 more
europepmc   +1 more source

Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape. [PDF]

ESMO Open
Gay F, Buda G, Petrucci MT, Bolli N, Cea M, Derudas D, Mangiacavalli S, Montefusco V, Antonioli E, Barilà G, Basso M, Bertazzoni P, Bertuglia G, Bianco R, Carlisi M, Giudice MLD, Pepa RD, Fazio F, Franceschini L, Furlan A, Gozzetti A, Liberatore C, Mancuso K, Martino EA, Mele G, Monaco F, Morè S, Paris L, Pavan L, Pezzatti S, Rago A, Ribolla R, Roncato R, Rossini B, Sgherza N, Vassallo F, Vincelli DI, Za T, Musto P, Zamagni E.   +39 more
europepmc   +1 more source